Literature DB >> 19583636

A new intravenous calcium channel blocker option to treat acute elevations in blood pressure.

Debbie L Cohen1, Raymond R Townsend.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19583636      PMCID： PMC8673156          DOI： 10.1111/j.1751-7176.2009.00132.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  10 in total

1.  The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients.

Authors:  Solomon Aronson; Cornelius M Dyke; Kevin A Stierer; Jerrold H Levy; Albert T Cheung; Philip D Lumb; Dean J Kereiakes; Mark F Newman
Journal:  Anesth Analg       Date:  2008-10       Impact factor: 5.108

2.  Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.

Authors:  J George Zhang; Shangara S Dehal; Thuy Ho; Jennifer Johnson; Catherine Chandler; Andrew P Blanchard; Robert J Clark; Charles L Crespi; David M Stresser; James Wong
Journal:  Drug Metab Dispos       Date:  2006-02-24       Impact factor: 3.922

3.  Clevidipine in adult cardiac surgical patients: a dose-finding study.

Authors:  James M Bailey; Wei Lu; Jerrold H Levy; James G Ramsay; Linda Shore-Lesserson; Richard C Prielipp; Neil W Brister; Gary W Roach; Ase Jolin-Mellgard; Margareta Nordlander
Journal:  Anesthesiology       Date:  2002-05       Impact factor: 7.892

4.  Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers.

Authors:  H Ericsson; U Bredberg; U Eriksson; A Jolin-Mellgård; M Nordlander; C G Regårdh
Journal:  Anesthesiology       Date:  2000-04       Impact factor: 7.892

Review 5.  Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control.

Authors:  Margareta Nordlander; Per-Ove Sjöquist; Hans Ericsson; Lars Rydén
Journal:  Cardiovasc Drug Rev       Date:  2004

6.  Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery.

Authors:  N Kieler-Jensen; A Jolin-Mellgård; M Nordlander; S E Ricksten
Journal:  Acta Anaesthesiol Scand       Date:  2000-02       Impact factor: 2.105

7.  Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension.

Authors:  Charles V Pollack; Joseph Varon; Norman A Garrison; Ramin Ebrahimi; Lala Dunbar; W Frank Peacock
Journal:  Ann Emerg Med       Date:  2008-06-05       Impact factor: 5.721

Review 8.  Hypertensive crises: challenges and management.

Authors:  Paul E Marik; Joseph Varon
Journal:  Chest       Date:  2007-06       Impact factor: 9.410

9.  Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial.

Authors:  Neil Singla; David C Warltier; Sweeta D Gandhi; Philip D Lumb; Robert N Sladen; Solomon Aronson; Mark F Newman; Howard L Corwin
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

Review 10.  Treatment of acute severe hypertension: current and newer agents.

Authors:  Joseph Varon
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.